Pharmacy Focus : Episode 73

Pharmacy Focus: AMCP Nexus 2023 - Recap on Biosimilar Updates

News
Podcast

On this month's episode, Pharmacy Times covers the Academy of Managed Care Pharmacy Nexus 2023 conference, highlighting the updates on biosimilars.

On this month's episode, Pharmacy Times covers the Academy of Managed Care Pharmacy Nexus 2023 conference, highlighting the updates on biosimilars. Interviews include: Chelsee Jensen, PharmD, BCPS a senior pharmacy specialist and pharmaceutical formulary manager at Mayo Clinic, Prerakkumar Parikh, PharmD, director of Specialty Clinical Solutions at Magellan Rx Management, and Kimberly Maxfield, PhD, from the FDA.

For more Nexus 2023 coverage, visit pharmacytimes.com.

Key Takeaways:

  1. Jensen discusses biosimilar approval updates, trends biosimilars, and what health care professionals can expect in the future.
  2. Parikh discusses the impact of interchangeable biosimilars, their cost-saving benefits, and the influx of biosimilars into pharmacy.
  3. Maxfield discusses the role pharmacists can take to reassure patients when switching to a biosimilar and the future of biosimilar development.
Related Videos
Pharmacist selling medications in the pharmacy | Image Credit: rh2010 - stock.adobe.com
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Portrait of young female pharmacist holding medication while using computer at pharmacy counter | Image Credit: Dragana Gordic - stock.adobe.com
biosimilar word or concept represented by wooden letter tiles on a wooden table with glasses and a book | Image Credit: lexiconimages - stock.adobe.com
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Laboratory test tubes and solution with stethoscope background. Science and Medical concept. Scientist research and analysis biotechnology concept - Image credit: Shutter2U | stock.adobe.com
Health care professional holding adalimumab
© 2024 MJH Life Sciences

All rights reserved.